In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition as amended and supplemented, and Article 10 of Decree No. 2-14-652 adopted for its implementation, as amended and supplemented, the Competition Council makes available to the public the ‘operation summary’ below, containing the information provided by the parties.<\/p>\n
This information was prepared by the notifying party, which is solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation.<\/p>\n
The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 adopted for the implementation of Law No. 104-12 on freedom of prices and competition, as amended and supplemented.<\/p>\n
Names of the companies and groups concerned:<\/strong><\/p>\n Nature of the operation<\/strong><\/p>\n Economic sectors concerned<\/strong><\/p>\n Deadline for interested third parties to submit their observations<\/strong><\/p>\n NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES<\/strong><\/p>\n The Competition Council received notification of an economic concentration operation concerning the acquisition by the company ‘Kairos Bidco AB’ of all the issued capital of the company ‘Karo Intressenter Holding AB’ (‘Karo Healthcare AB’ with its subsidiaries).<\/p>\n ‘Kairos Bidco AB’ (currently changing its name, previously ‘Goldcup 101388 AB’) is a Swedish limited liability company registered under number 559497-7471, with its registered office at c\/o TMF Sweden AB, Vasagatan 38, 111 20 Stockholm, Sweden. It is an acquisition vehicle fully and indirectly owned by investment funds, vehicles, and\/or accounts advised and managed by various subsidiaries of the company ‘KKR & Co. Inc.’ (with its subsidiaries, ‘KKR’).<\/p>\n ‘KKR’ is an international investment company that offers alternative asset management services as well as solutions related to capital and insurance markets. KKR manages investment funds that invest in private equity, credit, and real assets and has strategic partners managing hedge funds.<\/p>\n ‘Karo Healthcare AB’ is a Swedish limited liability company registered under number 59180-2052, with its registered office at Box 16184, 103 24 Stockholm, Sweden. It operates in the consumer healthcare sector and offers a wide range of everyday health products in various categories such as skin health, foot health, intimate health, digestive health, well-being, pain treatment, cough, cold, and specialized products.<\/p>\n <\/p>\n Done in Rabat on May 08, 2025.<\/p>\n","protected":false},"excerpt":{"rendered":" In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition as amended and supplemented, and Article 10 of Decree No. 2-14-652 adopted for its implementation, as amended and supplemented, the Competition Council makes available to the public the ‘operation summary’ below, containing the information provided by the parties. This information was prepared by the notifying party, which is solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation. The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 adopted for the implementation of Law No. 104-12 on freedom of prices and competition, as amended and supplemented. Names of the companies and groups concerned: The acquirer: ‘KKR & Co. Inc.’; The target: ‘Karo Intressenter Holding AB’. Nature of the operation Acquisition of exclusive control. Economic sectors concerned Pharmaceutical products market. Deadline for interested third parties to submit their observations 10 days from the date of publication of this press release, i.e., May 19, 2025. NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES The Competition Council received notification of an economic concentration operation concerning the acquisition by the company ‘Kairos Bidco AB’ of all the issued capital of the company ‘Karo Intressenter Holding AB’ (‘Karo Healthcare AB’ with its subsidiaries). ‘Kairos Bidco AB’ (currently changing its name, previously ‘Goldcup 101388 AB’) is a Swedish limited liability company registered under number 559497-7471, with its registered office at c\/o TMF Sweden AB, Vasagatan 38, 111 20 Stockholm, Sweden. It is an acquisition vehicle fully and indirectly owned by investment funds, vehicles, and\/or accounts advised and managed by various subsidiaries of the company ‘KKR & Co. Inc.’ (with its subsidiaries, ‘KKR’). ‘KKR’ is an international investment company that offers alternative asset management services as well as solutions related to capital and insurance markets. KKR manages investment funds that invest in private equity, credit, and real assets and has strategic partners managing hedge funds. ‘Karo Healthcare AB’ is a Swedish limited liability company registered under number 59180-2052, with its registered office at Box 16184, 103 24 Stockholm, Sweden. It operates in the consumer healthcare sector and offers a wide range of everyday health products in various categories such as skin health, foot health, intimate health, digestive health, well-being, pain treatment, cough, cold, and specialized products. Done in Rabat on May 08, 2025.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[352],"tags":[],"class_list":["post-39625","post","type-post","status-publish","format-standard","hentry","category-press-releases"],"acf":[],"yoast_head":"\n\n
\n
\n
\n